Standard
Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia : Influence on cure rates and risk of second cancer. / Levinsen, Mette; Rotevatn, Elisabeth Orskov; Rosthøj, Susanne; Nersting, Jacob; Abrahamsson, Jonas; Appell, Malin Lindqvist; Bergan, Stein; Bechensteen, Anne-Grete; Harila-Saari, Arja; Heyman, Mats; Jonsson, Olafur Gisli; Maxild, Jakob Bernhard Cohn; Niemi, Mikko; Soderhall, Stefan; Schmiegelow, Kjeld.
In:
Pediatric Blood & Cancer, Vol. 61, No. 5, 05.2014, p. 797-802.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Levinsen, M, Rotevatn, EO
, Rosthøj, S, Nersting, J, Abrahamsson, J, Appell, ML, Bergan, S, Bechensteen, A-G, Harila-Saari, A, Heyman, M, Jonsson, OG, Maxild, JBC, Niemi, M, Soderhall, S & Schmiegelow, K 2014, '
Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer',
Pediatric Blood & Cancer, vol. 61, no. 5, pp. 797-802.
https://doi.org/10.1002/pbc.24921APA
Levinsen, M., Rotevatn, E. O.
, Rosthøj, S., Nersting, J., Abrahamsson, J., Appell, M. L., Bergan, S., Bechensteen, A-G., Harila-Saari, A., Heyman, M., Jonsson, O. G., Maxild, J. B. C., Niemi, M., Soderhall, S., & Schmiegelow, K. (2014).
Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer.
Pediatric Blood & Cancer,
61(5), 797-802.
https://doi.org/10.1002/pbc.24921Vancouver
Levinsen M, Rotevatn EO
, Rosthøj S, Nersting J, Abrahamsson J, Appell ML et al.
Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer.
Pediatric Blood & Cancer. 2014 May;61(5):797-802.
https://doi.org/10.1002/pbc.24921Author
Levinsen, Mette ; Rotevatn, Elisabeth Orskov ; Rosthøj, Susanne ; Nersting, Jacob ; Abrahamsson, Jonas ; Appell, Malin Lindqvist ; Bergan, Stein ; Bechensteen, Anne-Grete ; Harila-Saari, Arja ; Heyman, Mats ; Jonsson, Olafur Gisli ; Maxild, Jakob Bernhard Cohn ; Niemi, Mikko ; Soderhall, Stefan ; Schmiegelow, Kjeld. / Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia : Influence on cure rates and risk of second cancer. In: Pediatric Blood & Cancer. 2014 ; Vol. 61, No. 5. pp. 797-802.
Bibtex
@article{33a7c956d9cf46c2ae0a00d8a71624fd,
title = "Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia: Influence on cure rates and risk of second cancer",
keywords = "ALL, late effects of cancer treatment, outcomes research, therapy",
author = "Mette Levinsen and Rotevatn, {Elisabeth Orskov} and Susanne Rosth{\o}j and Jacob Nersting and Jonas Abrahamsson and Appell, {Malin Lindqvist} and Stein Bergan and Anne-Grete Bechensteen and Arja Harila-Saari and Mats Heyman and Jonsson, {Olafur Gisli} and Maxild, {Jakob Bernhard Cohn} and Mikko Niemi and Stefan Soderhall and Kjeld Schmiegelow",
year = "2014",
month = may,
doi = "10.1002/pbc.24921",
language = "English",
volume = "61",
pages = "797--802",
journal = "Pediatric Blood & Cancer",
issn = "1545-5009",
publisher = "JohnWiley & Sons, Inc.",
number = "5",
}
RIS
TY - JOUR
T1 - Pharmacogenetically based dosing of thiopurines in childhood acute lymphoblastic leukemia
T2 - Influence on cure rates and risk of second cancer
AU - Levinsen, Mette
AU - Rotevatn, Elisabeth Orskov
AU - Rosthøj, Susanne
AU - Nersting, Jacob
AU - Abrahamsson, Jonas
AU - Appell, Malin Lindqvist
AU - Bergan, Stein
AU - Bechensteen, Anne-Grete
AU - Harila-Saari, Arja
AU - Heyman, Mats
AU - Jonsson, Olafur Gisli
AU - Maxild, Jakob Bernhard Cohn
AU - Niemi, Mikko
AU - Soderhall, Stefan
AU - Schmiegelow, Kjeld
PY - 2014/5
Y1 - 2014/5
KW - ALL
KW - late effects of cancer treatment
KW - outcomes research
KW - therapy
U2 - 10.1002/pbc.24921
DO - 10.1002/pbc.24921
M3 - Journal article
C2 - 24395436
VL - 61
SP - 797
EP - 802
JO - Pediatric Blood & Cancer
JF - Pediatric Blood & Cancer
SN - 1545-5009
IS - 5
ER -
